The table below shows Benitec Biopharma Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$0.00
$0.00
$0.00
-
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$6.30M
$5.83M
$3.37M
$2.87M
$6.50M
$5.38M
SG&A
BNTC annual revenue (10-K history)
Benitec Biopharma Inc. reported annual revenue of $0.00 for fiscal year 2024. That is down 100.0% from $75.00K in fiscal 2023. Over the 6 fiscal years shown, annual revenue declined from $12.20M (FY 2019) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.